Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy

PURPOSE: Single-agent interferon (IFN) is no longer regarded as a standard option for first-line systemic treatment of metastatic renal cell carcinoma (RCC) in Western countries. However, some patients with favorable-risk RCC may still achieve complete and long-lasting remission in response to IFN t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sazuka, Tomokazu, Nihei, Naoki, Nakamura, Kazuyoshi, Sakamoto, Shinichi, Fukasawa, Satoshi, Komaru, Atsushi, Ueda, Takeshi, Igarashi, Tatsuo, Ichikawa, Tomohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355431/
https://www.ncbi.nlm.nih.gov/pubmed/25763124
http://dx.doi.org/10.4111/kju.2015.56.3.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355431/
https://www.ncbi.nlm.nih.gov/pubmed/25763124
http://dx.doi.org/10.4111/kju.2015.56.3.205

Ejemplares similares